देश: तंज़ानिया
भाषा: अंग्रेज़ी
स्रोत: Tanzania Medicinces & Medical Devices Authority
Dapoxetine Hydrochloride
Berlin-Chemie AG, GERMANY
Other urologicals incl. Antispasmodics
Dapoxetine Hydrochloride
60 mg
Tablet, Film-coated
Menarini - Von Heyden GmbH (M H), GERMANY
Physical description: Grey, circular, convex, film-coated tablets debossed with ''60'' inside a triangle on one side and black on the other side; Local technical representative: Phillips Pharmaceuticals (Tanzania) Limited (2404)
Registered/Compliant
2021-03-29
TMDA/DMC/MRE/F/016 Version#1 TANZANIA MEDICINES AND MEDICAL DEVICES AUTHORITY PUBLIC ASSESSMENT REPORT FOR PRILIGY (DAPOXETINE HYDROCHLORIDE 60 MG) FILM COATED TABLETS VERSION NUMBER 1 MARCH, 2022 P. O. Box 77150, EPI Mabibo, Off Mandela Road, Dar es Salaam, Tanzania Tel: +255-22-2450512/2450751/ 2452108; Fax: +255-22-2450793 Email: info@tmda.go.tz; Website: mwww.tmda.go.tz 1. INTRODUCTION Priligy is an innovator product containing the active substance Dapoxetine hydrochloride. Dapoxetine hydrochloride, belonging to a class of drugs known as selective serotonin reuptake inhibitors with ATC code G04BX14. Serotonin is thought to play a role in ejaculatory reflex mediation and is believed to act centrally and peripherally to inhibit ejaculation, perhaps via the serotonin (5HT)1a receptor. The applicant has applied for the following indications: Priligy is indicated for the treatment of premature ejaculation (PE) in adult men aged 18 to 64 years. The applied indications have been approved in Tanzania. 1.1 PRODUCT DETAILS Registration number TAN 21 HM 0116 Brand name Priligy Generic name, strength and form Dapoxetine Hydrochloride 60 mg film coated tablets ATC classification G04BX14: Other urologicals Distribution category POM Country of origin Germany Associated product Priligy (Dapoxetine Hydrochloride 30 mg) film coated tablets registered with registration number TAN 20 HM 0628 Marketing Authorization Holder Berlin-Chemie AG (Menarmi Group), Glienicker Weg 125, 12489, Berlin, Germany. E-Mail: prijli@menarini.it Local Technical Representative Phillips Pharmaceuticals (Tanzania) Ltd, Vingunguti Industriai Area, Nyerere Road, P.O. Box 737, Dar Es Saalam, Tanzania. E-Mail: kunal.assar@phillipstanzania.co 1.2 ASSESSMENT PROCEDURE The application for registration of Priligy was submitted on 12 October, 2018. The product underwent abridged assessment. Assessment was completed in 3 (three) rounds of evaluation. Priligy was registered on <29/03/2021 > 1.3 INFORMATION FOR USERS Visual description of the finished product Grey पूरा दस्तावेज़ पढ़ें